SEC Form 4 · accession 0001624044-17-000005

Syneos Health, Inc. · SYNH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CAO, GC & Sec

Period of report

Jun 30, 2017

Accepted (ET)

Jul 5, 2017 · 7:42 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610950

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Jun 30, 2017	F	867	$58.50	D	47,450	D
Class A Common Stock	Jul 3, 2017	S	956	$58.55	D	46,494	D
Class A Common Stock	Jun 30, 2017	M	5,917	$16.06	A	52,411	D
Class A Common Stock^F2	Jun 30, 2017	S	5,917	$58.285	D	46,494	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F3	$16.06	Jun 30, 2017	M	5,917	D	—	Jun 30, 2024	Class A Common Stock	5,917	23,668	D

F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2016.
F2The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $58.20 to $58.42, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
F3One half of the shares subject to this option vest yearly in five equal installments beginning on June 30, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.